| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Departments of Medicine, McGill University, Royal Victoria Hospital, Montreal, Canada
2 Departments of Obstetrics and Gynecology, McGill University, Royal Victoria Hospital Montreal, Canada
The acute effect of pyridoxine (B6) on serum GH and PRL levels and its chronic effects on galactorrhea in nine subjects (group I, n = 4, idiopathic galactorrhea with normal PRL levels and normal menses; Group II, n = 5, galactorrheaamenorrhea with increased PRL levels) have been studied. Pyridoxine did not acutely alter GH or PRL levels. There was no decrease in galactorrhea, no resumption of menses and no decrease in PRL following two months of B6 therapy. In contrast, bromocriptine was effective in suppressing galactorrhea and restoring normal menses in group II subjects and remains the therapy of choice for this purpose.
Supported by the Quebec Research Council G.T- 750101 and the Medical Research Council of Canada HG, MT-4403; FN MT-5823.
Received November 2, 1976.
This article has been cited by other articles:
![]() |
S.-G. Ren and S. Melmed Pyridoxal Phosphate Inhibits Pituitary Cell Proliferation and Hormone Secretion Endocrinology, August 1, 2006; 147(8): 3936 - 3942. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Renwick Toxicology of Micronutrients: Adverse Effects and Uncertainty J. Nutr., February 1, 2006; 136(2): 493S - 501S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |